Cover Image

Is multisystem inflammatory syndrome related with coronavirus disease 2019, Kawasaki disease, and angiotensin-converting enzyme 2 in children?

Saved in:

Bibliographic Details
Main Author:	Lucy Youngmin Eun (Author)
Format:	Book
Published:	The Korean Pediatric Society, 2021-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Etiological and pathophysiological enigmas of severe coronavirus disease 2019, multisystem inflammatory syndrome in children, and Kawasaki disease
by: Jung-Woo Rhim, et al.
Published: (2022)

Potential use of the S-protein-Angiotensin converting enzyme 2 binding pathway in the treatment of coronavirus disease 2019
by: Long Feng, et al.
Published: (2022)

Multisystem inflammatory syndrome in adult with features of Kawasaki disease
by: Li Wei Heng, et al.
Published: (2024)

Preventive treatment of coronavirus disease-2019 virus using coronavirus disease-2019-receptor-binding domain 1C aptamer by suppress the expression of angiotensin-converting enzyme 2 receptor
by: Noor S Hameed, et al.
Published: (2023)

Dietary Potassium Downregulates Angiotensin-I Converting Enzyme, Renin, and Angiotensin Converting Enzyme 2
by: Carlos P. Vio, et al.
Published: (2020)

Angiotensin-converting enzyme inhibitors
by: David García Barreto, et al.
Published: (2014)

Comparison of early characteristics of multisystemic inflammatory syndrome and Kawasaki disease in children and the course of Kawasaki disease in the pandemic
by: Fatos Alkan, et al.
Published: (2024)

Multisystem Inflammatory Syndrome in Children: Unique Disease or Part of the Kawasaki Disease Spectrum?
by: Caterina Matucci-Cerinic, et al.
Published: (2021)

EXPERT CONSENSUS DOCUMENT ON ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN CARDIOVASCULAR DISEASE
by: Jose Lopez-Sendon, et al.
Published: (2015)

EXPERT CONSENSUS DOCUMENT ON ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN CARDIOVASCULAR DISEASE
by: Jose Lopez-Sendon, et al.
Published: (2015)

Similarities and Differences Between COVID-19-Related Multisystem Inflammatory Syndrome in Children and Kawasaki Disease
by: Min-Sheng Lee, et al.
Published: (2021)

Hyperkalemia Associated with Angiotensin Converting Enzyme Inhibitor or Angiotensin Receptor Blockers in Chronic Kidney Disease
by: Yudi Her Oktaviono, et al.
Published: (2020)

Clinical features, diagnosis, and outcomes of multisystem inflammatory syndrome in children associated with coronavirus disease 2019
by: Ji Hee Kwak, et al.
Published: (2021)

Multisystem inflammatory syndrome associated with coronavirus disease 2019: MIS-C-concepts and MIS-concepts
by: Pradeep Kumar Sharma
Published: (2021)

Differentiating Multisystem Inflammatory Syndrome in Children from Kawasaki Disease During the Pandemic
by: Seher Şener, et al.
Published: (2024)

Serum angiotensin converting enzyme in pemphigus vulgaris
by: Reza M Robati, et al.
Published: (2014)

Angiotensin-converting enzyme polymorphism and pediatric pneumonia
by: Nihal El Rifai, et al.
Published: (2018)

Angiotensin-converting enzyme gene polymorphism in autosomal dominant polycystic kidney disease
by: Sanjeev Nair, et al.
Published: (2014)

Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Angiotensin-Converting Enzyme 2 Levels: A Comprehensive Analysis Based on Animal Studies
by: Gábor Kriszta, et al.
Published: (2021)

Tissue Angiotensin II Generating System by Angiotensin-Converting Enzyme and Chymase
by: Mizuo Miyazaki, et al.
Published: (2006)

A neonate infected with coronavirus disease 2019 with severe symptoms suggestive of multisystem inflammatory syndrome in childhood
by: Fatemeh Eghbalian, et al.
Published: (2021)

Kawasaki Disease Shock Syndrome in Japan and Comparison With Multisystem Inflammatory Syndrome in Children in European countries
by: Junko Suzuki, et al.
Published: (2021)

Multisystem Inflammatory Syndrome with Features of Atypical Kawasaki Disease during the COVID-19 Pandemic
by: Reza Shahriarirad, et al.
Published: (2021)

Multisystem inflammatory syndrome in children and Kawasaki disease in infants: 2 sides of the same coin?
by: Hing Cheong Kok, et al.
Published: (2021)

Effects of Spironolactone in Combination with Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers in Patients with Proteinuria
by: Ha Yeon Kim, et al.
Published: (2014)

The Use of angiotensin converting enzyme inhibitors in chronic kidney disease - a review of the literature
by: Jakub Sosnowski, et al.
Published: (2023)

Angiotensin-Converting Enzyme Inhibitors and Adipokines: The Role of Visfatin and Apelin in Cardiovascular Disease Management
by: Yaseen Jumaah, et al.
Published: (2023)

Comparison of Eosinophil Counts in Inflammatory Conditions: Multisystem Inflammatory Syndrome in Children, Kawasaki Disease, and Infectious Mononucleosis
by: Erdal Sarı, et al.
Published: (2024)

The Fetal Safety of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers
by: Myla E. Moretti, et al.
Published: (2012)

Critical illness-associated brain microhemorrhages in a child with multisystem inflammatory syndrome secondary to coronavirus disease 2019
by: Diogo Goulart Corrêa, et al.
Published: (2021)

Similarities and Differences between Multisystem Inflammatory Syndrome in Children (MIS-C) and Kawasaki Disease Shock Syndrome
by: Jin Lee, et al.
Published: (2023)

Iron deficiency anemia as a predictor of coronary artery abnormalities in Kawasaki disease
by: Sohyun Kim, et al.
Published: (2019)

Effects of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Contrast-Induced Nephropathy
by: Letian Zhou, et al.
Published: (2014)

Structural determinants for binding to angiotensin converting enzyme 2 (ACE2) and angiotensin receptors
by: Daniel eClayton, et al.
Published: (2015)

CARDIOPROTECTIVE AND NEPHROPROTECTIVE EFFECTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITOR RAMIPRIL
by: D. A. Napalkov, et al.
Published: (2016)

CARDIOPROTECTIVE AND NEPHROPROTECTIVE EFFECTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITOR RAMIPRIL
by: D. A. Napalkov, et al.
Published: (2016)

Factors associated with non-adherence to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in older patients with peripheral arterial disease
by: Martin Wawruch, et al.
Published: (2023)

Anti-Inflammatory Properties of Drugs Used to Control COVID-19 and their Effects on the Renin-Angiotensin System and Angiotensin-Converting Enzyme-2
by: Hamed Gilzad-Kohan, et al.
Published: (2020)

Coronavirus disease 2019-related Kawasaki-like disease in an adult: A case report
by: Mohammad Yassine Chérif, MD, et al.
Published: (2020)

Angiotensin-Converting Enzyme 2 (ACE2) in the Context of Respiratory Diseases and Its Importance in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
by: Enrique Ambrocio-Ortiz, et al.
Published: (2021)